Xenon Pharmaceuticals (XENE)

• Market cap: $5.05B
• 1 day: 0.25%
• 5 days: 0.17%
• 1 month: -3.97%
• 3 months: -4.45%
• 6 months: 19.79%
• Year to date: 17.4%
• 1 year: 63.12%
• 5 years: 190.33%
• 10 years: 704.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Employees: 370